Edition:
United States

Bavarian Nordic A/S (BAVA.CO)

BAVA.CO on Copenhagen Stock Exchange

129.50DKK
16 Nov 2018
Change (% chg)

kr.-3.85 (-2.89%)
Prev Close
kr.133.35
Open
kr.134.65
Day's High
kr.135.30
Day's Low
kr.128.95
Volume
338,163
Avg. Vol
199,546
52-wk High
kr.262.00
52-wk Low
kr.128.95

Chart for

About

Bavarian Nordic A/S is a Denmark-based biotechnology company engaged in the development, production and marketing of vaccines for the treatment of cancer and infectious diseases. The Company’s drug pipeline comprises two areas: Cancer Immunotherapy and Infectious Disease. The Cancer Immunotherapy pipeline is focused on: prostate... (more)

Overall

Beta: 1.52
Market Cap(Mil.): kr.4,487.94
Shares Outstanding(Mil.): 32.31
Dividend: --
Yield (%): --

Financials

  BAVA.CO Industry Sector
P/E (TTM): -- 28.12 29.34
EPS (TTM): -13.90 -- --
ROI: -16.66 14.10 13.58
ROE: -18.11 15.67 15.11

Earnings vs. Estimates